Affimed Partners & Collaborators

Leveraging Affimed’s innate cell engager and fit-for-purpose ROCK® platform in strategic partnerships

Affimed fosters and continues to seek partnerships that are in line with the company’s overall corporate strategy to continue to move its clinical programs forward, enhance the development of Affimed’s internal pipeline and to allow for the technological advancement of our platform to realize the full potential of innate immune cells in oncology.

For partnership inquiries, please contact email hidden; JavaScript is required.


German Hodgkin Study Group (GHSG)

Leukemia & Lymphoma Society (LLS)

MD Anderson Cancer Center

Merck & Co., Inc.

NKGen Biotech, Inc.


Artiva Biotherapeutics, Inc.

Roivant Sciences